Immunodetection of pentamer and modified C-reactive protein using surface plasmon resonance biosensing
In clinical practices, the examination of pentamer C-reactive protein (pCRP) is commonly
used as a prognostic indicator of the risk of a patient developing cardiovascular disease …
used as a prognostic indicator of the risk of a patient developing cardiovascular disease …
[引用][C] Immunodetection of pentamer and modified C-reactive protein using surface plasmon resonance biosensing
WP Hu, HY Hsu, A Chiou, KY Tseng, HY Lin… - Biosensors and …, 2006 - cir.nii.ac.jp
Immunodetection of pentamer and modified C-reactive protein using surface plasmon resonance
biosensing | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
biosensing | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
Immunodetection of pentamer and modified C-reactive protein using surface plasmon resonance biosensing
WP Hu, HY Hsu, A Chiou, KY Tseng… - Biosensors & …, 2006 - pubmed.ncbi.nlm.nih.gov
In clinical practices, the examination of pentamer C-reactive protein (pCRP) is commonly
used as a prognostic indicator of the risk of a patient developing cardiovascular disease …
used as a prognostic indicator of the risk of a patient developing cardiovascular disease …
Immunodetection of pentamer and modified C-reactive protein using surface plasmon resonance biosensing.
WP Hu, HY Hsu, A Chiou, KY Tseng, HY Lin… - Biosensors & …, 2005 - europepmc.org
In clinical practices, the examination of pentamer C-reactive protein (pCRP) is commonly
used as a prognostic indicator of the risk of a patient developing cardiovascular disease …
used as a prognostic indicator of the risk of a patient developing cardiovascular disease …
[PDF][PDF] Immunodetection of pentamer and modified C-reactive protein using surface plasmon resonance biosensing
WP Hu, HY Hsu, A Chiou, KY Tseng, HY Lin… - Biosensors and …, 2006 - Citeseer
In clinical practices, the examination of pentamer C-reactive protein (pCRP) is commonly
used as a prognostic indicator of the risk of a patient developing cardiovascular disease …
used as a prognostic indicator of the risk of a patient developing cardiovascular disease …
Immunodetection of pentamer and modified C-reactive protein using surface plasmon resonance biosensing
WP Hu, HY Hsu, A Chiou, KY Tseng, HY Lin… - Biosensors and …, 2006 - infona.pl
In clinical practices, the examination of pentamer C-reactive protein (pCRP) is commonly
used as a prognostic indicator of the risk of a patient developing cardiovascular disease …
used as a prognostic indicator of the risk of a patient developing cardiovascular disease …
Immunodetection of pentamer and modified C-reactive protein using surface plasmon resonance biosensing
WP Hu, HY Hsu, A Chiou, KY Tseng… - Biosensors and …, 2006 - scholar.nycu.edu.tw
In clinical practices, the examination of pentamer C-reactive protein (pCRP) is commonly
used as a prognostic indicator of the risk of a patient developing cardiovascular disease …
used as a prognostic indicator of the risk of a patient developing cardiovascular disease …
[引用][C] Immunodetection of pentamer and modified C-reactive protein using surface plasmon resonance biosensing
WP HU, HY HSU, A CHIOU, KY TSENG… - Biosensors & …, 2006 - pascal-francis.inist.fr
Immunodetection of pentamer and modified C-reactive protein using surface plasmon
resonance biosensing CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
resonance biosensing CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
Immunodetection of pentamer and modified C-reactive protein using surface plasmon resonance biosensing
WP Hu, HY Hsu, A Chiou, KY Tseng… - Biosensors & …, 2006 - nckur.lib.ncku.edu.tw
In clinical practices, the examination of pentamer C-reactive protein (pCRP) is commonly
used as a prognostic indicator of the risk of a patient developing cardiovascular disease …
used as a prognostic indicator of the risk of a patient developing cardiovascular disease …